8-K
Current Report
Milestone Pharmaceuticals Inc. Filed Acc 0001104659-20-087533
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading tm2025424d2_8k.htm…